Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
The biggest drag on blue chips was Pfizer (PFE, Fortune 500), which reported earnings per share that beat by just a penny. The drugmaker reaffirmed its outlook, but investors were hoping for more. Shares fell 2.8%. Financial...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.